St. Jude Medical (NYSE:STJ) is one of the relatively few large-cap medical technology companies managing to deliver ongoing growth through this tough part of the cycle. Unfortunately for shareholders, there is a great deal of uncertainty about whether St. Jude is going to continue to deliver enough growth to make the stock appealing for the long-haul.

IN PICTURES: 9 Simple Investing Ratios You Need To Know

The Quarter That Was
St. Jude reported total revenue growth of 7% for the third quarter, with the company's large CRM (cardiac rhythm management) business growing at 7%, and the smaller atrial fibrillation and neuromodulation businesses growing 8% and 11% respectively. Relative to "same-store" results from Boston Scientific (NYSE:BSX) and off-calendar comparisons to Medtronic (NYSE:MDT), St. Jude is almost certainly capturing shares in the large and lucrative (but slow-growing) CRM market. That is a good thing, as that is 60% of the company's business.

It seems as though every company has "one time" charges every quarter these days, so assessing St. Jude's profitability is subject to that disclaimer. Still, it appears that gross margin fell by about 150 basis points from last year, while operating income rose just under 10%. Those are not bad numbers per se, but the lower gross margin is a reason for pause. (For more, see Money To Be Made In Medical Devices.)

The Road Ahead
St. Jude has done well with past acquisitions (like Radi, Endocardial Solutions and Advanced Neuromodulation), and that should give investors some confidence that the recent deal for AGA Medical (Nasdaq:AGAM) will pay off in time. The question, though, is whether that will be enough. True, AGAM has four potential $1 billion product opportunities (which would almost double St. Jude's current revenue base), but the odds of going four-for-four are long (especially for AGAM's migraine application).

Longer term, the company needs to drive both revenue growth and higher cash flow efficiency. The company has benefited in the past from lower tax rates and so on, but those are not necessarily repeatable. That places an ongoing burden on the company to improve operating efficiency just to hold the line on its free cash flow conversion. (For related reading, check out 5 Stocks With Solid Cash Flow.)

The Bottom Line
St. Jude is unlikely to take a big swing and buy a company like Edwards Lifesciences (NYSE:EW), though a deal for a company like ZOLL (Nasdaq:ZOLL), Abiomed (Nasdaq: ABMD) or Thoratec (Nasdaq:THOR) could be viable. On its own, though, St. Jude will have its work cut out achieving the free cash flow growth it needs.

As it stands, St. Jude is probably slightly undervalued at today's price. Adding just 1% to the 10-year free cash flow growth rate would boost that target by about 6%, so that is the scale of the leverage that St. Jude faces. At today's prices, there are more interesting healthcare ideas, but St. Jude is at least holding its own in tough times. (For more, see Investing In The Healthcare Sector.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Economics

    Investing Opportunities as Central Banks Diverge

    After the Paris attacks investors are focusing on central bank policy and its potential for divergence: tightened by the Fed while the ECB pursues easing.
  2. Stock Analysis

    The Biggest Risks of Investing in Pfizer Stock

    Learn the biggest potential risks that may affect the price of Pfizer's stock, complete with a fundamental analysis and review of other external factors.
  3. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  4. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  5. Markets

    PEG Ratio Nails Down Value Stocks

    Learn how this simple calculation can help you determine a stock's earnings potential.
  6. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  7. Investing

    What’s the Difference Between Duration & Maturity?

    We look at the meaning of two terms that often get confused, duration and maturity, to set the record straight.
  8. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  9. Stock Analysis

    When Will Dick's Sporting Goods Bounce Back? (DKS)

    Is DKS a bargain here?
  10. Investing News

    How AT&T Evolved into a Mobile Phone Giant

    A third of Americans use an AT&T mobile phone. How did it evolve from a state-sponsored monopoly, though antitrust and a technological revolution?
  1. What does low working capital say about a company's financial prospects?

    When a company has low working capital, it can mean one of two things. In most cases, low working capital means the business ... Read Full Answer >>
  2. Do nonprofit organizations have working capital?

    Nonprofit organizations continuously face debate over how much money they bring in that is kept in reserve. These financial ... Read Full Answer >>
  3. Can a company's working capital turnover ratio be negative?

    A company's working capital turnover ratio can be negative when a company's current liabilities exceed its current assets. ... Read Full Answer >>
  4. Does working capital measure liquidity?

    Working capital is a commonly used metric, not only for a company’s liquidity but also for its operational efficiency and ... Read Full Answer >>
  5. How do I read and analyze an income statement?

    The income statement, also known as the profit and loss (P&L) statement, is the financial statement that depicts the ... Read Full Answer >>
  6. Can working capital be too high?

    A company's working capital ratio can be too high in the sense that an excessively high ratio is generally considered an ... Read Full Answer >>

You May Also Like

Trading Center